Here is the data point that should alarm public health officials: searches for Ozempic side effects peaked in mid-2024 and have since dropped by 58%, falling from a score of 100 to just 42 by March 2026
We at Klinic focus strictly on these branded, FDA-approved medications to ensure safety and efficacy and refrain from prescribing compounded weight loss drugs
Companies including Pfizer, Eli Lilly, and Structure Therapeutics are leading the charge in developing novel orals
Safe alternatives include metformin, SGLT2 inhibitors (empagliflozin, dapagliflozin), DPP-4 inhibitors (sitagliptin, linagliptin), and exenatide immediate-release or lixisenatide, which do not carry thyroid cancer warnings
LATIN AMERICA GLUTATHIONE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION) TABLE 266